Gain Therapeutics (GANX) Leases (2020 - 2025)
Gain Therapeutics (GANX) has 6 years of Leases data on record, last reported at $184422.0 in Q3 2025.
- For Q3 2025, Leases fell 34.5% year-over-year to $184422.0; the TTM value through Sep 2025 reached $184422.0, down 34.5%, while the annual FY2024 figure was $219715.0, 52.15% down from the prior year.
- Leases reached $184422.0 in Q3 2025 per GANX's latest filing, down from $233200.0 in the prior quarter.
- Across five years, Leases topped out at $901042.0 in Q4 2021 and bottomed at $183664.0 in Q1 2025.
- Average Leases over 5 years is $515764.8, with a median of $499017.0 recorded in 2021.
- Peak YoY movement for Leases: skyrocketed 72.26% in 2021, then tumbled 52.19% in 2025.
- A 5-year view of Leases shows it stood at $901042.0 in 2021, then decreased by 26.76% to $659933.0 in 2022, then tumbled by 30.41% to $459215.0 in 2023, then crashed by 52.15% to $219715.0 in 2024, then decreased by 16.06% to $184422.0 in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $184422.0 in Q3 2025, $233200.0 in Q2 2025, and $183664.0 in Q1 2025.